Pozen.

PositionStatewide: TRIANGLE REGION - Acquisition of Tribute Pharmaceuticals Canada - Brief article

CHAPEL HILL -- Drug developer Pozen will acquire Milton, Ontario-based Tribute Pharmaceuticals Canada for about $146 million and move its headquarters from here to Ireland. The company will be renamed Aralez Pharmaceuticals. Adrian Adams will be chief executive officer, succeeding John Plachetka, who founded Pozen in 1996 and...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT